LEXINGTON, Mass.–(BUSINESS WIRE <https://www.businesswire.com/>
)–KabaFusion (the “Company”), a nationally recognized leader in
home and alternative site infusion, and Nautic Partners
(“Nautic”) announced today that Nautic has signed a definitive
agreement to make a significant investment in KabaFusion.
KabaFusion’s clinician-led management team will remain
significant investors and continue to lead the Company, while
Novo Holdings will exit its successful investment in the Company.
The new growth partnership with Nautic will allow the Company to
accelerate and further expand its mission to serve patients,
healthcare practitioners, and payers nationwide with the highest
quality home infusion services and unmatched clinical excellence.
Headquartered in Cerritos, CA and Lexington, MA, KabaFusion was
founded in 2010 by Chief Executive Officer Dr. Sohail Masood, a
pioneer in patient-focused intravenous immunoglobulin (IVIG)
infusion therapies with more than three decades of clinical
experience. Today, KabaFusion is licensed to serve patients in 45
states through its expansive network of 32 infusion pharmacies
and 19 ambulatory infusion suites. The Company recently expanded
its footprint by acquiring six infusion care pharmacy locations
from Coram Infusion Services, entering new strategic markets and
further strengthening its commitment to delivering high-quality,
patient-focused care.
Dr. Sohail Masood, CEO and founder of KabaFusion, said, “We are
incredibly proud of what KabaFusion has accomplished-delivering
innovative, patient-focused infusion therapies and setting the
standard for clinical excellence nationwide. We have known the
Nautic team for a long time and they are a natural partner for
our business and the management team. As we enter this exciting
new chapter, we look forward to leveraging Nautic’s expertise to
accelerate our growth. We are confident this partnership will
further strengthen our ability to deliver exceptional outcomes
and lasting value for the patients and providers we serve.”
“Our investment in KabaFusion embodies Nautic’s strategy to
partner with and support outstanding management teams focused on
delivering differentiated value to the providers, payers, and
most importantly, the patients they serve,” said Chris Corey,
Managing Director at Nautic. “We have long admired Dr. Masood and
the rest of the team at KabaFusion and hold the deepest respect
and appreciation for the impact KabaFusion brings every day. We
could not be more enthused to partner with Dr. Masood and his
team and to support their continued success.”
About KabaFusion
KabaFusion is a national provider of essential chronic and acute
infusion therapies. The company serves patients in 45 states
through its nationwide network of home infusion pharmacies,
alternative infusion sites, and home health agencies. KabaFusion
was founded in 2010 by Chief Executive Officer Dr. Sohail Masood,
a pioneer in patient focused infusion therapies with more than 30
years of clinical experience. The company is dedicated to working
proactively with patients, healthcare practitioners, and payors
to provide comprehensive support before, during and after
treatment. For more information, visit Kabafusion.com.
About Nautic Partners
Nautic Partners, LLC is a middle-market private equity firm based
in Providence, Rhode Island, that focuses on investments in three
sectors: healthcare, industrials, and services. Nautic has
completed over 160 platform transactions over its 38-year
history. The firm employs a proactive, thematic investment
strategy and partners with strong management teams to accelerate
the growth of its portfolio companies through strategic add-on
acquisitions, targeted operational initiatives, and deep sector
expertise. For more information, please visit www.nautic.com
<https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2
Fwww.nautic.com&esheet=54313296&newsitemid=20250826047615&lan=en-
US&anchor=www.nautic.com&index=1&md5=f771b0c4787897161043a47a8b6c
7f92> .
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
